New Blood Test Promises Hope for Pancreatic Cancer

Preliminary results were presented this week at a cancer research conference in California and showed that a type of blood test called a “liquid biopsy” was key to achieving a 97% accuracy rate at diagnosing the most common type of pancreatic cancer during early stages.